Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer

NACompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2015

Conditions
Gastric Cancer
Interventions
DEVICE

CellSearch® CTC kit

"Collect peripheral blood sample of 100 gastric cancer patients pre-chemotherapy treated with capecitabine/paclitaxel (XPa) and capecitabine/cisplatin (XP) and post two cycles of chemotherapy(response evaluation).~Blood samples will be transferred to central lab to detect CTCs by Cellsearch kit.~Tumor response evaluation will be performed after two cycles of chemotherapy by CT/MRI based on RECIST. Clinical data, including tumor stage, metastastic organ, chemotherapy regimen, objective response, progression free survival, overall survival, etc, will be collected according to study protocol."

Trial Locations (1)

100142

Department of GI Oncology, Peking University Cancer Hospital, Beijing

All Listed Sponsors
lead

Peking University

OTHER

NCT01625702 - Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer | Biotech Hunter | Biotech Hunter